Multi-dose Ibuprofen Prophylaxis for IUD-insertion

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Pelvic Pain, IUD

In brief

This study compares the effectiveness of decreasing pain at time of and day after intrauterine device (IUD) insertion when patients take three doses of Ibuprofen versus three doses of placebo.

Key facts

Study ID

NCT03868137

Run by

Orlando VA Medical Center

People needed

86

Starts

2020-09-28

Expected to finish

2022-05-01

Last updated by the study team

2020-10-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18
• Female
• Able to provide informed consent
• English speaking
• Able to provide telephone and address contact information
• Able and willing to receive HIPAA compliant telephone texts and phone messages
• Stable (the same) address and phone number within the last 6 months.

You may not qualify if…

• Contraindications to IUD insertion (active pelvic infection, current pregnancy)
• Contraindications to NSAIDs (allergy, history of asthma, history of aspirin allergy, history of kidney disease, history of stomach ulcer, history of active GI bleeding, history of liver disease)
• Not undergoing any other concurrent office procedures

Where it is running

• Orlando VA Medical Center — Orlando, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.